<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Baker DL</submitter><funding>Western Sydney University</funding><funding>National Institutes of Health</funding><funding>NIGMS NIH HHS</funding><funding>NIH HHS</funding><pagination>1308-1317</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11471385</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>92(11)</volume><pubmed_abstract>The ongoing global pandemic of the coronavirus 2019 (COVID-19) disease is caused by the virus SARS-CoV-2, with very few highly effective antiviral treatments currently available. The machinery responsible for the replication and transcription of viral RNA during infection is made up of several important proteins. Two of these are nsp12, the catalytic subunit of the viral polymerase, and nsp9, a cofactor of nsp12 involved in the capping and priming of viral RNA. While several recent studies have determined the structural details of the interaction of nsp9 with nsp12 in the context of RNA capping, very few biochemical or biophysical details are currently available. In this study, we have used a combination of surface plasmon resonance (SPR) experiments, size exclusion chromatography (SEC) ex</pubmed_abstract><journal>Proteins</journal><pubmed_title>A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.</pubmed_title><pmcid>PMC11471385</pmcid><funding_grant_id>R01 GM067153</funding_grant_id><funding_grant_id>GM067153</funding_grant_id><pubmed_authors>Artsimovitch I</pubmed_authors><pubmed_authors>Kwan AH</pubmed_authors><pubmed_authors>Cubeddu L</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Gamsjaeger R</pubmed_authors><pubmed_authors>Ataide SF</pubmed_authors><pubmed_authors>Allport TA</pubmed_authors><pubmed_authors>Baker DL</pubmed_authors><pubmed_authors>Wilkinson-White LE</pubmed_authors><pubmed_authors>El-Kamand S</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Biochemical and Biophysical Analysis of the Interaction of nsp9 with nsp12 from SARS-CoV-2-Implications for Future Drug Discovery Efforts.</name><description>The ongoing global pandemic of the coronavirus 2019 (COVID-19) disease is caused by the virus SARS-CoV-2, with very few highly effective antiviral treatments currently available. The machinery responsible for the replication and transcription of viral RNA during infection is made up of several important proteins. Two of these are nsp12, the catalytic subunit of the viral polymerase, and nsp9, a cofactor of nsp12 involved in the capping and priming of viral RNA. While several recent studies have determined the structural details of the interaction of nsp9 with nsp12 in the context of RNA capping, very few biochemical or biophysical details are currently available. In this study, we have used a combination of surface plasmon resonance (SPR) experiments, size exclusion chromatography (SEC) ex</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Nov</publication><modification>2026-06-02T20:56:57.955Z</modification><creation>2025-06-25T03:06:14.981Z</creation></dates><accession>S-EPMC11471385</accession><cross_references><pubmed>38958516</pubmed><doi>10.1002/prot.26725</doi></cross_references></HashMap>